Vanguard Group Inc Codexis, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,724,941 shares of CDXS stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,724,941
Previous 4,463,801
5.85%
Holding current value
$11.9 Million
Previous $21.3 Million
40.31%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CDXS
# of Institutions
141Shares Held
64.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$23.8 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$20.3 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$17 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$7.53 Million1.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.83MShares$7.1 Million0.34% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $164M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...